Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
22.70
+0.50 (2.25%)
At close: Apr 27, 2026
-5.42%
Market Cap 1.01B
Revenue (ttm) 449.47M
Net Income (ttm) 74.55M
Shares Out 44.34M
EPS (ttm) 1.68
PE Ratio 13.51
Forward PE n/a
Dividend 1.50 (6.61%)
Ex-Dividend Date n/a
Volume 22,183
Average Volume 12,305
Open 22.80
Previous Close 22.20
Day's Range 22.30 - 22.80
52-Week Range 19.40 - 26.40
Beta 0.61
RSI 56.01
Earnings Date Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.76 million, an increase of 19.13%.

Financial Statements

News

There is no news available yet.